FDA Inspection 1249592 — Saint Alphonsus Institutional Review Board

Saint Alphonsus Institutional Review Board — FEI 3003637724

The FDA completed an inspection of Saint Alphonsus Institutional Review Board on Sep 18, 2024 in Boise, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boise, ID (United States)

Additional Details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews
768621 CFR 56.106(b)(3)Number of active protocols
769221 CFR 56.106(e)Changes in contact or chairperson information